Travere TherapeuticsTVTX
那斯達克 · USD
27.24
-0.07
(-0.26%)
收盤 03/07 04:59 (UTC+8)
盤後
27.70
+0.46
(+1.69%)
03/07 04:59 (UTC+8)
Travere TherapeuticsTVTX
27.24
-0.07
(-0.26%)
財務數據
損益表
- 0.37
- 0.45
- 0.41
- 0.54
- 0.63
- 0.75
- 0.82
- 1.14
- 1.65
- 1.30
- -56.77
- 21.47
- -8.18
- 30.80
- 16.23
- 18.90
- 9.29
- 40.03
- 44.05
- -21.33
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 129,689 | 164,859 | 114,448 | 81,732 | 74,787 | 62,898 | 54,116 | 41,374 | 45,059 | 37,095 |
營業成本 | 2,553 | 1,585 | 1,522 | 4,679 | 2,553 | 1,626 | 2,061 | 1,504 | 4,564 | 1,289 |
營業毛利 | 127,136 | 163,274 | 112,926 | 77,053 | 72,234 | 61,272 | 52,055 | 39,870 | 40,495 | 35,806 |
營業費用 | 159,564 | 138,343 | 125,579 | 119,727 | 132,971 | 117,421 | 119,759 | - | 134,728 | 128,391 |
研發費用 | 57,870 | 51,890 | 49,362 | 46,889 | 62,067 | 51,679 | 54,330 | 49,420 | 59,746 | 60,590 |
推銷及管理費用 | 101,694 | 86,453 | 76,217 | 72,838 | 69,501 | 65,619 | 64,776 | 64,223 | 63,588 | 67,801 |
非經常性項目費用 | - | - | - | - | 1,403 | 123 | 653 | 65,464 | 11,394 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -32,428 | 24,931 | -12,653 | -42,674 | -60,737 | -56,149 | -67,704 | -139,237 | -94,233 | -92,585 |
其他收入及費用 | 13,659 | 3,533 | 2,763 | 4,344 | 3,214 | 4,090 | 925 | 6,270 | 8,526 | 6,176 |
利息費用 | 2,296 | 2,750 | 2,845 | 2,857 | 2,817 | 2,777 | 2,788 | 2,800 | 2,821 | 2,820 |
稅前純益 | -21,065 | 25,714 | -12,735 | -41,187 | -60,340 | -54,836 | -69,567 | -135,767 | -88,528 | -89,229 |
所得稅 | 921 | 8 | 20 | 39 | -72 | -84 | 85 | 191 | 68 | 12 |
稅後純益 | 2,729 | 25,706 | -12,755 | -41,226 | -60,264 | -54,811 | -70,409 | -136,061 | -90,173 | 150,735 |
基本每股稅後盈餘(元) | 0.03 | 0.29 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 | -1.76 | -1.18 | 1.97 |
稀釋每股稅後盈餘(元) | 0.03 | 0.28 | -0.14 | -0.47 | -0.71 | -0.70 | -0.91 | -1.76 | -1.21 | 2.09 |
基本平均股數(千股) | 90293.00 | 89230.00 | 88945.00 | 88355.00 | 83105.00 | 77779.00 | 77500.00 | 77136.00 | 76474.00 | 76305.00 |
稀釋平均股數(千股) | 90293.00 | 102618.00 | 88945.00 | 88355.00 | 83105.00 | 77779.00 | 77500.00 | 77136.00 | 76474.00 | 76305.00 |
還原基本每股稅後盈餘(元) | 0.03 | 0.29 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 | -1.76 | -1.18 | 1.97 |
還原稀釋每股稅後盈餘(元) | 0.03 | 0.28 | -0.14 | -0.47 | -0.71 | -0.70 | -0.91 | -1.76 | -1.21 | 2.09 |
還原基本平均股數(千股) | 90,293 | 89,230 | 88,945 | 88,355 | 83,105 | 77,779 | 77,500 | 77,136 | 76,474 | 76,305 |
還原稀釋平均股數(千股) | 90,293 | 102,618 | 88,945 | 88,355 | 83,105 | 77,779 | 77,500 | 77,136 | 76,474 | 76,305 |
EBITDA(千元) | 21,287 | 44,252 | 4,126 | -25,528 | -48,238 | -40,879 | -57,191 | -123,190 | -83,534 | 159,861 |